跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Colate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Colate
Approved
STANDARD
Colate
Swiss Parenterals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0d9ffa93fd5d8af4
Company
Swiss Parenterals Ltd.
Type
Standard
Approval Details
Approval Id
0d9ffa93fd5d8af4
Drug Approval Philippines Name
Colate
Product Name
Colate
Registration Number
DRP-13944
Brand Name
Colate
Generic Name
Colistimethate Sodium
Dosage Form
Lyophilized Powder For Injection (I.V.)
Dosage Strength
160 mg (equivalent to 2, 000, 000 IU)
Manufacturer
Swiss Parenterals Ltd.
Importer
Biocare Lifesciences, Inc.
Distributor
Biocare Lifesciences, Inc.
Issuance Date
24 May 2023
Expiry Date
24 May 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0d9ffa93fd5d8af4
Type
Standard
Back to Philippines FDA Approvals